MARKET

BHC

BHC

Bausch Health Companies Inc
NYSE

Real-time Quotes | Nasdaq Last Sale

8.76
+1.49
+20.50%
After Hours: 8.62 -0.14 -1.60% 16:11 06/24 EDT
OPEN
7.68
PREV CLOSE
7.27
HIGH
8.76
LOW
7.50
VOLUME
16.64M
TURNOVER
0
52 WEEK HIGH
30.30
52 WEEK LOW
6.88
MARKET CAP
3.17B
P/E (TTM)
-7.6835
1D
5D
1M
3M
1Y
5Y
CANADA STOCKS - TSX rises 1.93% to 19,077.91
reuters.com · 2h ago
Zendesk, Quotient, + 40 Stocks Moving In Friday's Mid-Day Session
Gainers USA Truck, Inc. (NASDAQ: USAK) shares jumped 111% to $30.76. DB Schenker and USA Truck announced plans to combine and create premier North American transportation solutions provider.
Benzinga · 6h ago
CANADA STOCKS-Toronto index rebounds on tech, healthcare boost
reuters.com · 8h ago
Anebulo, Tenon top healthcare gainers; BioSig, Rigel lead losers' pack
Gainers: Anebulo Pharmaceuticals (ANEB) +32%. Tenon Medical (TNON) +19%. PolarityTE (PTE) +14%. TRACON Pharmaceuticals (TCON) +14%. Bausch Health (BHC) +13%. Losers: BioSig Technologies (BSGM) -26%. Rigel Pharmaceuticals (RIGL) -8%. Valneva (VALN) -8%. Mer...
Seekingalpha · 8h ago
Bausch Health Appoints John Paulson Chair After Joseph Papa Resigns; Shares Rise
MT Newswires · 10h ago
Bausch Health Names Hedge Fund Billionaire Paulson Chairman
(Bloomberg) -- Bausch Health Cos. named hedge fund billionaire John Paulson as its new chairman, replacing Joseph Papa, who resigned Thursday.Most Read from BloombergJuul’s Vaping Products Are Ordered Off the Market in the USThese Are the World’s Most Live...
Bloomberg · 11h ago
Bausch Health's Joe Papa resigns from board, John Paulson named chairperson
Bausch Health Companies Inc. disclosed Friday that Joseph Papa has resigned from the board of directors as of June 23. The specialty pharmaceutical company named John Paulson as its chairperson of the board. The company said Papa's resignation from the boa...
marketwatch.com · 12h ago
Bausch Health board chairman Joseph Papa resigns, co taps John Paulson as replacement
Bausch Health (NYSE:BHC) on Thursday said its chairman Joseph Papa had resigned from the board, effective immediately. BHC said it had appointed John Paulson to the board to replace Papa upon his
Seekingalpha · 1d ago
More
No Data
Learn about the latest financial forecast of BHC. Analyze the recent business situations of Bausch Health Companies Inc through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 9 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

11.11%Strong Buy
44.44%Buy
33.33%Hold
11.11%Under-perform
0.00%Sell
Analyst Price Target
The average BHC stock price target is 23.86 with a high estimate of 40.00 and a low estimate of 7.00.
High40.00
Average23.86
Low7.00
Current 8.75
EPS
Actual
Estimate
0.320.640.961.28
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Institutional Holdings
Institutions: 542
Institutional Holdings: 269.11M
% Owned: 74.45%
Shares Outstanding: 361.48M
TypeInstitutionsShares
Increased
117
16.95M
New
58
7.04M
Decreased
107
17.92M
Sold Out
60
10.98M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
+2.68%
Pharmaceuticals & Medical Research
+2.48%
Key Executives
Chairman/Chief Executive Officer/Director
Joseph Papa
Chief Financial Officer/Executive Vice President
Sam Eldessouky
Corporate Executive
Thomas Appio
Corporate Executive
Joseph Gordon
Executive Vice President/General Counsel
Christina Ackermann
Lead Director
Thomas Ross
Independent Director
Richard De Schutter
Independent Director
Brett Icahn
Independent Director
Argeris Karabelas
Independent Director
Sarah Kavanagh
Independent Director
Steven Miller
Independent Director
John Paulson
Independent Director
Robert Power
Independent Director
Russel Robertson
Independent Director
Andrew von Eschenbach
Independent Director
Amy Wechsler
No Data
No Data
About BHC
Bausch Health Companies Inc. is a specialty pharmaceutical and medical device company. The Company is engaged in developing, manufacturing, and marketing a range of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products, and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment and aesthetics devices), which are marketed directly or indirectly in over 100 countries. Its segments include Bausch + Lomb, Salix, Ortho Dermatologics, International Rx and Diversified Products. The Bausch + Lomb segment consists of sales in the United States of Bausch + Lomb Vision Care, Consumer, Surgical and Ophthalmology Rx products. The Salix segment consists of sales in the United States of gastroenterology (GI) products. The Ortho Dermatologics segment consists of sales in the United States of Ortho Dermatologics (dermatological) products and global sales of Solta medical aesthetic devices.

Webull offers kinds of Bausch Health Companies Inc stock information, including NYSE:BHC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BHC stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading BHC stock methods without spending real money on the virtual paper trading platform.